Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
EMJ GOLD
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
Hideki Garren on rethinking multiple sclerosis care
Hideki Garren explores how our understanding of MS is evolving, the challenge of measuring disease progression and what the future holds.
Read more
Unpicking pharma’s reputation in pop culture
Helena is joined by Paul Simms, CEO, Impatient Health, to delve deeper into GOLD’s cover feature on reframing pharma’s bad boy reputation.
In conversation with GSK's Rino Rappuoli
This week, Helena and Isabel are honoured to be joined by Rino Rappuoli, Head of External R&D and Chief Scientist at GSK Vaccines.
Top tips for digital innovation and the future of patient centricity
Helena is joined by well-known pharma conference speaker Konrad Dobschuetz to discuss his top tips for digital innovation in the pharma industry.
Medical affairs, commercial and enhancing soft skills
In this episode, Helena hosts a medical affairs discussion with Novartis UK’s Samin Saeed about leadership, company culture, soft skills development and much more.
Pharmacovigilance past, present and future
Marc and Helena are joined by Pav Rishiraj, Director and Head of Pharmacovigilance, Ipsen, to shed light on this often-overlooked field.
Meet GOLD’s new catalyst – medical aficionado Juby Jacob-Nara
An exclusive version of our conversation Juby Jacob-Nara (Sanofi) about how former physicians can empower themselves to succeed in the pharmaceutical industry.
Season finale: MMR and vaccines past, present and future
As Helena and Marc wrap up this season, they’re joined by Mike Watson, CEO of Mevox, to discuss past present and future of vaccines.
Key pharma trends from Cannes Lions
In this episode, Helena and Marc are joined by Claire Gillis, CEO, VMLY&R Health, to discuss the health and pharma highlights from the recent Cannes Lions.
Big pharma vs biotech and the future of marketing
Helena and Marc are joined by Michele Manto, CCO, Galapagos, and Robert Grimm, Digital Marketing and Transformation Manager, Novo Nordisk.
Meet GOLD's recent catalyst – Claus Zieler
In this episode, Helena and Marc are joined by Claus Zieler, President of Established Markets, Astellas, to discuss leadership and crisis management.
Medical affairs evolution and the future for MSLs
Marc, Helena and the team are joined by Luca Dezzani, Vice President, Oncology Medical Affairs, J&J, to talk all things medical affairs. Listen now!
Men's Health Week special
In this Men’s Health Week special, the GOLD team is joined by Peter Baker, Director, Global Action on Men’s Health and Chumi Khurana, Global
Killing projects, drug discovery and career progression
This week, the GOLD team is joined by Eric Bouilloux, Chief Development Officer, Istesso, to talk about immunometabolism and pharma predictions.
Gamification: retaining a human touch and enhancing culture
In this episode, GOLD is joined by Natalie Yeadon, Co-founder and CEO of Impetus Digital to talk all things gamification in pharma.
Getting to grips with customer experience
Join Isabel and Jade in kicking off Season 5 of the GOLD podcast with an interview with Philippe Kirby, Global Head of Channel Engagement and Execution, MSD.
Pharma in South Africa, access, pricing and reimbursement
In this episode, GOLD is joined by two international experts in market access, talking about pricing, reimbursement and more in South Africa and Europe.
Learnings from the Next Pharma Summit
In this bonus episode, Helena offers her reflections on the Next Pharma Summit, and Isabel catches up with the event founder Dario Safaric.
Communication, data in R&D and leadership
In this episode, Helena and Marc are joined by Amgen’s Emma Booth to discuss all things R&D, plus medical affairs communication and more.
Mental health: awareness, access and influence in pharma
For this episode, the team is joined by Wendy Bartie, BMS, and Courtney Billington, Janssen Neuroscience, to talk all things mental health: awareness, access and influence in pharma.
Social sustainability, patient advocacy and policy campaigning
In this episode, Marc and Helena are joined by Leo Pharma’s Klaus League to discuss social sustainability, patient advocacy and policy campaigning.
RWE, the metrics of medical affairs and TikTok marketing
Marc and Helena are joined by Luisa Luciani-Silverman, US Medical Head of Immuno-Oncology at AstraZeneca, and many more guests, talking medical affairs, RWE and TikTok marketing.
Driving access to digital, gene therapies and rare disease education
In this episode, Marc and Helena talk about digital access with Alira Health’s Aaron Grandy and about haemophilia with patient advocate Laurence Woollard.
2022 pharma predictions – where are we now?
In this episode, at the season’s half way point, Marc, Helena and Isabel look back at our 2022 predictions for pharma industry – were our guests right?
Meet GOLD's next catalyst - digital innovator, Davidek Herron
Marc presents exclusive snippets from an interview with our next catalist, Davidek Herron, Global Head of Digital, Roche.
Loading posts...
« Previous
1
…
13
14
15
16
17
…
27
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View